Archie Lovatt PhD
Archie joined Vitrology as a Founder in 2007 and provides regulatory consultancy and scientific direction to Vitrology. In his previous position as Scientific Director of Invitrogen Bioservices he was successful in many areas. He pioneered the development and implementation of quantitative PCR and PERT services for the testing of biological products. During his 11 years with this company he built several highly successful development, validation and operational teams and was critical to implementing the Q-One Biotech and BioReliance R&D pipeline over the past decade.

Until 2005, he focused on molecular biology and virology divisions, and also in the routine lot release testing operations under GLP/cGMP compliance. Thereafter he played a key role in technical regulatory services, business development, and in the strategic direction of the Invitrogen Bioservices R&D pipeline.

Prior to his bio-industrial career Archie held positions in academia. In 1990, he graduated from University of Glasgow with a BSc in microbiology. He then worked at the Medical Sciences Institute, University of Leicester researching the genetic analysis of microbial virulence factors, and graduated with a Ph.D in molecular microbiology. In 1994, he was awarded a post doctoral fellowship at the Cancer Research UK Beatson Institute to genetically dissect transcriptional factors and investigate their role in central nervous system cellular differentiation.

Archie provides excellent knowledge in R&D, assay development, scientific operations, technical regulatory affairs, business development and the identification of technology trends to meet customer requirements.